CN113603757A - Lilium regale Dirigent similar protein gene LrDI 1 and application - Google Patents
Lilium regale Dirigent similar protein gene LrDI 1 and application Download PDFInfo
- Publication number
- CN113603757A CN113603757A CN202110957491.9A CN202110957491A CN113603757A CN 113603757 A CN113603757 A CN 113603757A CN 202110957491 A CN202110957491 A CN 202110957491A CN 113603757 A CN113603757 A CN 113603757A
- Authority
- CN
- China
- Prior art keywords
- lrdir1
- gene
- plant
- tobacco
- dirigent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 61
- 241001634091 Lilium regale Species 0.000 title claims abstract description 18
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 33
- 241000208125 Nicotiana Species 0.000 claims abstract description 29
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 241000223221 Fusarium oxysporum Species 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 241001503951 Phoma Species 0.000 claims description 3
- 241001066584 Phoma neerlandica Species 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 abstract description 52
- 230000009261 transgenic effect Effects 0.000 abstract description 31
- 230000000843 anti-fungal effect Effects 0.000 abstract description 9
- 239000013604 expression vector Substances 0.000 abstract description 5
- 208000031888 Mycoses Diseases 0.000 abstract description 4
- 244000061176 Nicotiana tabacum Species 0.000 abstract description 4
- 230000002018 overexpression Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- 206010017533 Fungal infection Diseases 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 25
- 108020004414 DNA Proteins 0.000 description 18
- 241000234435 Lilium Species 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000012634 fragment Substances 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241000233866 Fungi Species 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 229920005610 lignin Polymers 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 238000010353 genetic engineering Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 244000053095 fungal pathogen Species 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229930013686 lignan Natural products 0.000 description 3
- 150000005692 lignans Chemical class 0.000 description 3
- 235000009408 lignans Nutrition 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 240000008100 Brassica rapa Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 101710120781 Dirigent protein Proteins 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000234280 Liliaceae Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000233647 Phytophthora nicotianae var. parasitica Species 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 241000589615 Pseudomonas syringae Species 0.000 description 2
- 101710088278 Pterocarpan synthase 1 Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241001123668 Verticillium dahliae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- YQGZIRIYGHNSQO-ZPFDUUQYSA-N Arg-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YQGZIRIYGHNSQO-ZPFDUUQYSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- IARGXWMWRFOQPG-GCJQMDKQSA-N Asn-Ala-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IARGXWMWRFOQPG-GCJQMDKQSA-N 0.000 description 1
- AYOAHKWVQLNPDM-HJGDQZAQSA-N Asn-Lys-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AYOAHKWVQLNPDM-HJGDQZAQSA-N 0.000 description 1
- BUVNWKQBMZLCDW-UGYAYLCHSA-N Asp-Asn-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BUVNWKQBMZLCDW-UGYAYLCHSA-N 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011292 Brassica rapa Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 101710114460 Dirigent-like protein Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 1
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 1
- LLZLRXBTOOFODM-QSFUFRPTSA-N Ile-Asp-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N LLZLRXBTOOFODM-QSFUFRPTSA-N 0.000 description 1
- YNMQUIVKEFRCPH-QSFUFRPTSA-N Ile-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O)N YNMQUIVKEFRCPH-QSFUFRPTSA-N 0.000 description 1
- DLEBSGAVWRPTIX-PEDHHIEDSA-N Ile-Val-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)[C@@H](C)CC DLEBSGAVWRPTIX-PEDHHIEDSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 description 1
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- JOYFULUKJRJCSX-IUCAKERBSA-N Met-Met-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O JOYFULUKJRJCSX-IUCAKERBSA-N 0.000 description 1
- ZDJICAUBMUKVEJ-CIUDSAMLSA-N Met-Ser-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O ZDJICAUBMUKVEJ-CIUDSAMLSA-N 0.000 description 1
- AGYXCMYVTBYGCT-ULQDDVLXSA-N Phe-Arg-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O AGYXCMYVTBYGCT-ULQDDVLXSA-N 0.000 description 1
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 1
- WPTYDQPGBMDUBI-QWRGUYRKSA-N Phe-Gly-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O WPTYDQPGBMDUBI-QWRGUYRKSA-N 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- LCRSGSIRKLXZMZ-BPNCWPANSA-N Pro-Ala-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LCRSGSIRKLXZMZ-BPNCWPANSA-N 0.000 description 1
- CNUIHOAISPKQPY-HSHDSVGOSA-N Pro-Thr-Trp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O CNUIHOAISPKQPY-HSHDSVGOSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 1
- OQSQCUWQOIHECT-YJRXYDGGSA-N Ser-Tyr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OQSQCUWQOIHECT-YJRXYDGGSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- JXKMXEBNZCKSDY-JIOCBJNQSA-N Thr-Asp-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O JXKMXEBNZCKSDY-JIOCBJNQSA-N 0.000 description 1
- RKDFEMGVMMYYNG-WDCWCFNPSA-N Thr-Gln-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O RKDFEMGVMMYYNG-WDCWCFNPSA-N 0.000 description 1
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- WKGAAMOJPMBBMC-IXOXFDKPSA-N Thr-Ser-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WKGAAMOJPMBBMC-IXOXFDKPSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 1
- XMNDQSYABVWZRK-BZSNNMDCSA-N Tyr-Asn-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XMNDQSYABVWZRK-BZSNNMDCSA-N 0.000 description 1
- WPXKRJVHBXYLDT-JUKXBJQTSA-N Tyr-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N WPXKRJVHBXYLDT-JUKXBJQTSA-N 0.000 description 1
- NXPDPYYCIRDUHO-ULQDDVLXSA-N Tyr-Val-His Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 NXPDPYYCIRDUHO-ULQDDVLXSA-N 0.000 description 1
- HZWPGKAKGYJWCI-ULQDDVLXSA-N Tyr-Val-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O HZWPGKAKGYJWCI-ULQDDVLXSA-N 0.000 description 1
- BZMIYHIJVVJPCK-QSFUFRPTSA-N Val-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N BZMIYHIJVVJPCK-QSFUFRPTSA-N 0.000 description 1
- YKNOJPJWNVHORX-UNQGMJICSA-N Val-Phe-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YKNOJPJWNVHORX-UNQGMJICSA-N 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- -1 aromatic alcohols Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 108010084553 jacalin Proteins 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 108010084572 phenylalanyl-valine Proteins 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 230000008659 phytopathology Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a Lilium regale Dirigent analogous protein geneLrDIR1The nucleotide sequence is shown as SEQ ID NO. 1, and the protein with the amino acid sequence shown as SEQ ID NO. 2 is coded, and the invention is proved by related technical research of functional genomicsLrDIR1The gene has the function of improving the antifungal effect of plants, and the invention is antifungalLrDIR1The gene is constructed on a plant expression vector and is transferred into tobacco for over-expression, a transgenic tobacco plant has strong capability of resisting fungal infection, and the experimental result shows that the over-expression is realizedLrDIR1The transgenic tobacco is used for treating fusarium oxysporum and grass stemsInfestation by molds is resistant.
Description
Technical Field
The invention relates to the technical field related to molecular biology and genetic engineering, in particular to a lilium regale Dirigent similar protein gene with antifungal infection capacityLrDIR1And application thereof.
Background
Plants are more or less stressed by biotic or abiotic factors during their growth, limiting their growth and development to varying degrees, thereby affecting the development of the final economic and yield traits of the plants. Among various adverse stress factors, diseases caused by bacteria, fungi, viruses, etc. are major factors that impair the growth and development of plants. The cultivation of resistant plant species and the use of pesticides are the main methods for solving the problem of plant diseases at present. The traditional breeding mode has the defects of long period, difficulty in obtaining resistance sources, easiness in losing resistance of resistant varieties and the like, so that the problem of plant diseases cannot be fundamentally solved. In recent years, molecular biology and genetic engineering techniques are rapidly developed, a large number of disease-resistant genes are separated and cloned from different plants, the period for cultivating plant disease-resistant varieties by using the genetic engineering technique is short, and a new variety with strong resistance can be obtained by combining different disease-resistant genes, so that the defects of traditional disease-resistant breeding can be well overcome.
During the infection of plants by pathogens, the substances secreted by the pathogens induce the immune system of the plants to respond to the attack of the pathogens. Plant-pathogen interaction has been a research hotspot in phytopathology. In response to the attack by pathogenic bacteria, plants have evolved a variety of structural and resistance proteins against pathogenic bacteria. For example, plants produce lignin to strengthen cell walls, synthesize phytoalexins (e.g., toxic phenolic compounds), and accumulate various disease-related proteins (pathologically related proteins). In recent years, disease-related proteins, lectins, dirigent (dir), and the like have been attracting attention as plant-produced disease-resistant proteins.
The Dirigent protein was first produced by Davin et al in Forsythia suspensa (Forsythia intermedia) In (1) foundIt can capture free radicals of lignin monomers and direct them to form polymeric lignin and oligomeric lignans, which are further involved in plant defense reactions, while lignin can enhance the lignification degree of plant cell walls, increase the mechanical strength of cell walls, and further inhibit the infection of phytopathogens (Davin L B, Wang H B, brown a L, et al. Stereoselective biological chemical ligation by an animal pathogen an active center, Science 1997, 275: 362-. The firmness of the cell wall in plant cells directly affects their resistance to pathogenic bacteria. Lignin is a group of substances consisting of polymerized aromatic alcohols, present in the xylem, and mainly functions to harden the cell walls by forming a cross-woven network, being the primary component of secondary walls. The DIR protein family is also involved in the synthesis of lignans. Lignans are most isolated from magnolia bark, such as magnolol. The DIR protein family genes are divided into six subfamilies, namely DIR-a, DIR-b/d, DIR-c, DIR-e, DIR-f and DIR-G, sequence analysis shows that the sequence similarity among the six subfamilies is very low, wherein only DIR-a can guide lignin to synthesize a correct three-dimensional structure, and the biochemical functions of other subfamilies are not known, so that the subfamilies except DIR-a are also called DIR-like (DIR-like) genes (Ralph S G, Jancsik S, Bohlmann J. variant gene in gene promoter destination II: Extended gene discovery, phylogeny, and constraint and stress-induced gene expression vectorPicea spp.). Phytochemistry, 2007, 68(14): 1975-1991)。
DIR proteins have been found in many plants and studies have shown that DIR proteins affect the disease resistance and ability to resist abiotic stress in plants (Weidenbach D, Esch L, Mller C, et al. Polarized feed against fungal pathogens is mediated by the jacalin-related molecules of the modelPoaceaeMolecular Plant, 2016, 9(4): 514-. Wheat (Triticum aestivum L.)TaDIR13Overexpression in tobacco upregulated P.syringae: (Pseudomonas syringae) And Phytophthora nicotianae (Phytophthora nicotianae) Resistance (Qinghu Ma, Yunchao Liu. TaDIR13, a dirigent protein from wHeat, proteins biosyntheses and industries pathway resistance. Plant Molecular Biology Reporter, 2015, 33(1): 143-. When turnip (A), (B), (C)Brassica rapa) Inoculating Fusarium oxysporum (F.), (Fusarium oxysporum) After that, the air conditioner is started to work,BrDIR-like-2the expression level of (A) was significantly up-regulated, 5 times higher than that of (A) uninoculated (Arasan S T, Park J I, Ahmed N U, et al, Characterization and expression of differential family genes related to strains inBrassicaPlant Physiol Biochem, 2013, 67: 144-. Olive for preventing diseasesOlea europaea) In the variety of the strain,DIRthe transcription level of the gene is in Verticillium wilt bacterium (Verticillium dahliae) The early stages of infection are greatly increased (Leyva-Perez Mar i a de la O, Jimeez-Ruiz Jaime, G Lou mez-Lama Caban s Carmen, et al, Tolerance of olive: (Leyva-P rez Mar i a de la O, Jim nez-Ruiz Jaime, G Lou mez-Lama Caban s Carmen, et alOlea europaea) cv Frantoio to Verticilliumdahliae relies on both basal and pathogen-induced differential transcriptomic responses. The New phytologist, 2018, 217217: 671-686)。
The Bulbus Lilii is Liliaceae (Liliaceae) Lilium (Lilium)Lilium) The plant is a general term of perennial root flower. During the processes of seed ball propagation and fresh cut flower production, lily is vulnerable to various pathogenic bacteria such as fungi, viruses and bacteria. The lily diseases found at present are more than dozens, among which, the lily is from the genus Fusarium (A), (B), (CFusarium spp.) blight caused by fungi (also known as basal rot, stem rot) is the most serious disease in lily production. After the fusarium infects the lily seed balls, the basal disc is necrotic, the scales are rotted and fall off, and the quality of the seed balls is reduced; after the plants are infected by fusarium, the leaves turn yellow and droop wilting, and the plants die in advance, so that the yield and the quality of the cut lily flowers are seriously influenced. Wherein Fusarium oxysporum (F.), (F. oxysporum) The pathogenicity is strongest, the separation frequency is highest, and the lily is the main pathogenic bacterium of lily wilt. Lilium regale (Lilium regale)L. regale Wilson) is a unique species in China, is only distributed in rock cracks from valleys with the altitude of 800-. Dirigent is involved in responding to various biotic stresses and is an important group of plant defense systemsThe gene is a part, so that important research and application values are provided for the discovery and functional analysis of the Dirigent gene in Lilium regale.
Disclosure of Invention
The invention aims to provide a Lilium regale Dirigent analogous protein geneLrDIR1And its application in increasing the resistance of tobacco to Fusarium oxysporum (F.B.)F. oxysporum) Phoma graminearum (A) and (B)Phoma herbarum) Use in resistance.
The dirigent-like protein gene with antifungal activity, which is cloned from Lilium regaleLrDIR1The full-length gene of (a),LrDIR1the nucleotide sequence is shown as SEQ ID NO. 1, the gene cDNA full length sequence is 867bp, comprises an open reading frame of 504bp, a 5 'untranslated region of 146 bp, a 3' untranslated region of 217 bp, and encodes protein of the amino acid sequence shown as SEQ ID NO. 2.
In the inventionLrDIR1The coding region of the gene is a nucleotide sequence shown in the 147-650 th site of the sequence table SEQ ID NO: 1.
The invention separates and clones a complete cDNA segment of an antifungal related gene of Lilium regale, and utilizes agrobacterium tumefaciens (A), (B) and (C)Agrobacterium tumefaciens) The target gene is transferred into a receptor plant and is overexpressed, whether the gene has antifungal activity is verified through further experiments, a foundation is laid for the capability of improving tobacco and other plants to resist fungal diseases by utilizing the gene in the later period, and the inventor names the gene asLrDIR1。
As described aboveLrDIR1The gene can be applied to improving the antifungal property of tobacco, and the specific operation is as follows:
(1) using amplificationLrDIR1The specific primer is used for extracting total RNA from the root of Lilium regale after inoculating fusarium oxysporum and amplifying the total RNA by reverse transcription-polymerase chain reaction (RT-PCR)LrDIR1Then connecting the full-length coding region to a pGEM-T vector, and obtaining a clone with a target gene through sequencing;
(2) using restriction endonucleasesXbaI andEcoenzyme digestion of pGEM-T-LrDIR1Carrier, obtained by glue recoveryThe gene fragment is obtained by digesting the plant expression vector pCAMBIA2300s with the same endonuclease, recovering the gel to obtain the large fragment of the required vector, and obtaining the large fragment of the required vectorLrDIR1Connecting the gene fragment with the pCAMBIA2300s fragment to construct a plant overexpression vector, and then transferring the constructed recombinant vector into tobacco to express through the mediation of agrobacterium tumefaciens;
(3) screening transformants by using a resistance marker on the recombinant vector T-DNA, obtaining a real transgenic plant through PCR and RT-PCR detection, analyzing the capability of total protein of the transgenic plant leaf for inhibiting the growth of pathogenic fungi in vitro, and finally screening the transgenic plant with obviously enhanced resistance to the fungi.
The invention provides a new method for improving the resistance of plants to fungal diseases, overcomes the defects of the traditional breeding by cultivating disease-resistant plants by a genetic engineering means, shortens the breeding period, is simple to operate and is easy to obtain high-resistance materials. The invention is derived from Lilium regaleLrDIR1The gene can enhance the resistance of plants to fungi, and the gene is introduced into tobacco, so that new varieties and new materials with fungal resistance can be generated; the cultivation of resistant plant varieties and materials by utilizing the genetic engineering technology has obvious advantages and irreplaceable importance; the invention not only can provide convenience for large-scale production of crops, medicinal materials, horticultural plants and the like, greatly reduces the use of chemical pesticides, but also can save the cost for agricultural production and reduce the environmental pollution, thereby having wide market application prospect.
Drawings
FIG. 1 is a drawing of the present inventionLrDIR1PCR detection result graph of transgenic tobacco genome DNA, in the graph: the Marker is DL2000 DNA Marker (Dalibao biology); the positive control is plasmid pGEM-T-LrDIR1PCR products as templates; WT is the product of PCR using total DNA of non-transgenic tobacco (wild type) as template;
FIG. 2 shows the positivity of the present inventionLrDIR1In transgenic tobaccoLrDIR1A graph of the results of expression analysis at the transcriptional level; in the figure: marker is DL2000 DNA Marker (Dalibao biology); WT is a PCR product with non-transgenic tobacco total RNA reverse transcription cDNA as a template; the positive control was plasmid pGEM-T-LrDIR1As a template PCR product;
FIG. 3 is a drawing of the present inventionLrDIR1The analysis result graph of the in vitro antifungal activity of the transgenic tobacco; the fungi shown in panels a and b are Fusarium oxysporum and Phoma herbarum, respectively; WT was the wild type tobacco total protein and Buffer was the blank, i.e., no protein control (Buffer used to extract protein).
Detailed Description
The present invention is further illustrated by the following figures and examples, but the scope of the present invention is not limited to the above description, and the examples are conventional methods unless otherwise specified, and reagents used are conventional commercially available reagents or reagents formulated according to conventional methods unless otherwise specified.
Example 1:LrDIR1gene cloning and sequence analysis
Inoculating fusarium oxysporum to Lilium regale, extracting total RNA from roots inoculated for 24 hours, grinding the inoculated Lilium regale roots into powder by using liquid nitrogen, transferring the powder into a centrifuge tube, extracting the total RNA by using a guanidine isothiocyanate method, synthesizing a cDNA first chain by using reverse transcriptase M-MLV (promega) and using the total RNA as a template, wherein a reaction system and an operation process are as follows: taking 5 μ g of Total RNA, adding 50ng oligo (dT), 2 μ L dNTP (2.5 mM each) and DEPC water in sequence to the reaction volume of 14.5 μ L; after uniformly mixing, heating and denaturing at 70 ℃ for 5min, then rapidly cooling on ice for 5min, then sequentially adding 4 mu L of 5 XFirst-stand buffer, 0.5 mu L of RNase (200U) and 1 mu L M-MLV (200U), uniformly mixing and centrifuging for a short time, carrying out warm bath at 42 ℃ for 1.5h, taking out, heating at 70 ℃ for 10min, and stopping reaction; the first strand cDNA is synthesized and stored at-20 deg.C for further use.
Amplifying target gene using synthesized first strand cDNA as templateLrDIR1The sequences of the upstream and downstream primers used were 5 'CGCTAGCTGCAAAAAAGTTGA 3' and 5 'GAAACGATGAATAACCCATGATTTT 3', respectively. Advantage is takenTM2 PCR Enzyme (Clontech) amplifies the target gene; and (3) PCR reaction conditions: 5min at 94 ℃; 30s at 94 ℃, 30s at 60 ℃, 1min at 72 ℃ and 32 cycles; 10min at 72 ℃; the reaction system (20. mu.L) was 0.5. mu.L of cDNA, 2. mu.L of 10 × Advantage 2 PCR Buffer, 0.4. mu.L of 50 × dNTP Mix (10 mM each), 0.4. mu.L of forward primer (10. mu.M), and 0.4. mu.L of reverse primerPrimers (10. mu.M), 0.4. mu.L of Advantage 2 PCR Polymerase Mix, 15.9. mu.L of PCR-Grade water; after the PCR was completed, 5. mu.L of the resulting mixture was subjected to agarose gel electrophoresis to examine the specificity and size of the amplified product.
The PCR product was TA cloned using pGEM-T Vector System I (Promega, USA) as a kit, and the reaction System and procedure were as follows: mu.L of the PCR product was taken, and 1. mu.L of pGEM-T Vector (50 ng/. mu.L) and 2.5. mu.L of 2 × Ligation solution I were sequentially added thereto, mixed well and then left to react at 16 ℃ overnight. The ligation product was transformed into E.coli DH 5. alpha. using a heat shock transformation method. Screening positive clones with LB solid medium containing ampicillin (Ampicillin, Amp), selecting several single colonies, shaking, and amplifyingLrDIR1Identifying the multiple cloning site insertionLrDIR1The clones identified are sequenced and finally obtainedLrDIR1The full-length cDNA was 867bp and was found to contain a 504bp open reading frame by NCBI ORF finder (http:// www.ncbi.nlm.nih.gov/gorf. html) analysis (see sequence listing),LrDIR1encodes a protein containing 167 amino acids, and has a molecular weight of about 17.69KDa and an isoelectric point of about 9.25. Analysis by means of bioinformatics software SignalP5.0LrDIR1The encoded protein sequence, detecting whether it has an N-terminal signal peptide; the results are shown inLrDIR1The signal peptide is present at the N-terminus of (A), and therefore the protein is presumed to be a secreted protein.
Example 2: construction of plant overexpression vectors
The insertion is extracted by adopting a SanPrep column type plasmid DNA small extraction kit (Shanghai worker)LrDIR1The E.coli plasmid pGEM-T-LrDIR1And the plasmid of the plant expression vector pCAMBIA2300s, taking 1 microliter to be used for agarose gel electrophoresis to detect the integrity and concentration of the extracted plasmid; using restriction endonucleasesXbaI (TaKaRa) andEcoRI (TaKaRa) against plasmid pGEM-T-LrDIR1And pCAMBIA2300s (100 mu L system), wherein the reaction system and the operation process are as follows: separately, 20. mu.L of pGEM-T-LrDIR1And pCAMBIA2300s plasmid, 10. mu.L 10 XK buffer, and 4. mu.LXbaI、6μL EcoRI、60μL ddH2O, mixingAfter being homogenized, the mixture is centrifuged for a short time and is placed at 37 ℃ for overnight reaction; all the products of the digestion are spotted in agarose gel for electrophoresis, and thenLrDIR1The fragments and the pCAMBIA2300s vector large fragment are respectively subjected to gel recovery, and a SanPrep column type DNA gel recovery kit (Shanghai's engineering) is used in the whole process; taking 1 microliter of the recovered product, detecting the size and concentration of the recovered fragment by agarose gel electrophoresis, and storing at-20 ℃ for later use.
The recovered DNA was purified by using T4 DNA Ligase (TaKaRa)LrDIR1 The DNA fragment and the pCAMBIA2300s vector fragment were ligated, and the reaction system (20. mu.L) and the procedure were as follows: taking 10 μ LLrDIR1 The DNA fragment was sequentially added with 2. mu.L of pCAMBIA2300s vector DNA, 2. mu.L of 10 XT 4 DNA Ligase Buffer, 1. mu. L T4 DNA Ligase, and 5. mu.L of ddH2And O, mixing uniformly, centrifuging for a short time, and then carrying out water bath at 16 ℃ for overnight reaction. The ligation product was then transferred into E.coli DH 5. alpha. by heat shock transformation, and positive clones were selected on a solid medium containing 50mg/L kanamycin (Km). Selecting single colony shake bacteria, taking bacteria liquid as template for amplificationLrDIR1The specific primers of (1) are subjected to PCR, and selectedLrDIR1If the detected strain is positive, the clone successfully connected with pCAMBIA2300s is added with glycerol and stored at-80 ℃ for later use.
Extraction and purification of pCAMBIA2300s-LrDIR1Plasmid, then freezing and thawing the plant expression vector pCAMBIA2300s-LrDIR1Transferred into Agrobacterium tumefaciens LBA4404 competent cells. The operation steps are as follows: taking 2 μ g of pCAMBIA2300s-LrDIR1The plasmid is added into a centrifuge tube containing 200 mu L of competent cells, the mixture is gently mixed and then is subjected to ice bath for 5min, then the mixture is transferred into liquid nitrogen to be frozen for 1min, then the mixture is rapidly placed in a water bath at 37 ℃ for 5min, then is subjected to ice bath for 2min immediately, and is added with 800 mu L of LB liquid culture medium to be subjected to shaking culture at 28 ℃ for 4 h. The activated agrobacterium is spread on LB solid culture medium containing 50mg/L Km and is statically cultured at 28 ℃. Selecting single colony shake bacteria, and amplifyingLrDIR1The specific primer of (2) is used for PCR to detect pCAMBIA2300s-LrDIR1If the positive clone is transferred into agrobacterium, adding glycerol into the positive clone, and storing the positive clone at-80 ℃ for later use.
Example 3: agrobacterium-mediated genetic transformation of plants and transgenic plant screens
The transgenic recipient in this experiment was tobacco, tobacco seeds were soaked in 75% ethanol for 30s, washed with sterile water and then washed with 0.1% HgCl2Soaking for 8min, washing with sterile water for several times, sowing on 1/2MS culture medium, dark culturing at 28 deg.C for 6d, germinating, transferring to light incubator (25 deg.C, 16 h/d light), and subculturing with 1/2MS culture medium once a month.
The preserved liquid containing pCAMBIA2300s was taken out from the-80 ℃ refrigeratorLrDIR1Agrobacterium LBA4404 strain of plasmid was inoculated into 5mL LB liquid medium containing 50mg/L Km and 20mg/L rifampicin, and cultured at 28 ℃ until the medium became turbid. Sucking 1mL of turbid bacterial liquid to an LB solid culture medium containing 50mg/L Km, and culturing for 48h at 28 ℃; then, appropriate amount of the agrobacteria on LB solid medium was scraped and inoculated into MGL liquid medium supplemented with 20mg/L acetosyringone, and shake-cultured at 28 ℃ for 2-3 h to activate the agrobacteria.
Cutting sterile tobacco seedling leaf into 1cm2And completely soaking the left and right leaf discs in the MGL liquid culture medium containing the activated agrobacterium for 15min, sucking bacterial liquid on the surfaces of the leaves by using sterile filter paper, placing the leaf discs on a co-culture medium for room temperature culture, wherein the co-culture medium for tobacco transformation is MS +0.02 mg/L6-BA +2.1mg/L NAA +30g/L sucrose +6g/L agar, and co-culturing for 2 days at 22 ℃ in the absence of light.
Transferring the co-cultured leaf disc to an MS screening culture medium added with antibiotics to be divided into seedlings, and screening transgenic plants at the same time, wherein the tobacco screening culture medium is MS +0.5 mg/L6-BA +0.1mg/L NAA +30g/L sucrose +6g/L agar +50mg/L Km +200mg/L cephamycin (Cef); during screening culture, the culture bottle is transferred to an illumination culture box for culture (25 ℃, 16 h/d illumination and 8 h/d darkness), after the tobacco grows out of buds, the MS culture medium containing 50mg/L Km and 200mg/L Cef is used for subculture, the regeneration plant needs to be further screened because the callus differentiation rate of the tobacco is higher, the tobacco regeneration seedling is transferred to the MS culture medium containing 50mg/L Km to root the tobacco regeneration seedling, and finally the regeneration seedling with better rooting is selected for further detection.
Extracting by a CTAB methodTaking genome DNA of transgenic tobacco plant leaf, taking 1 mu L of the extracted genome DNA, detecting the integrity and concentration of the extracted genome DNA by agarose gel electrophoresis, and taking the genome DNA of the transgenic plant as a template for amplificationLrDIR1The specific primer of (2) is used for PCR, 8 mu L of product is used for agarose gel electrophoresis after the PCR is finished to detect positive transgenic plants, the amplification result of part of tobacco transgenic plants is shown in figure 1,LrDIR1and (4) screening 40 positive transgenic plants from the transgenic tobacco.
Example 4: in transgenic tobaccoLrDIR1Expression analysis and functional analysis of transgenic plants against fungal infection
Taking positive transgenic single plant and tender leaf of non-transgenic tobacco (wild type) to extract total RNA, reverse transcribing to generate first strand cDNA, and using it as template to make amplificationLrDIR1The specific primers are used for carrying out PCR, and each transgenic individual is analyzed according to the PCR resultLrDIR1The expression of transcription level, total RNA extraction and RT-PCR were performed as in example 1, after PCR was completed, 8. mu.L of the DNA was subjected to agarose gel electrophoresis, and the results of detection of some individuals were shown in FIG. 2, and 35 transgenic individuals were detected in totalLrDIR1The expression was carried out at the transcriptional level in a large amount, and the numbers of these individuals were 1 to 35.
Several kinds of pathogenic fungi stored in a laboratory are inoculated on a PDA solid culture medium (200 g/L of potato, 15g/L of agar and 20g/L of glucose), dark culture is carried out at 28 ℃, plant protein is added when bacterial colonies grow to be about 2-3cm in diameter, and the in-vitro antifungal activity of transgenic plants is analyzed. In order to prevent other bacteria from polluting the extracted protein, the whole process of extracting the vegetable protein is aseptic operation. Firstly, 1 g of single transgenic tobacco plant (numbered L-4, L-7 and L-8 respectively) and wild type leaves are put into a mortar, 1mL of protein extract (1M NaCL, 0.1M sodium acetate and 1% PVP, pH6.0) is added, and the mixture is fully ground. Transferring into a 1.5mL centrifuge tube, mixing uniformly, and standing overnight at 4 ℃. Centrifuge at 4 deg.C for 30min (12,000g/min), take the supernatant in a new 1.5mL centrifuge tube, and take an appropriate amount to determine the total protein concentration with an ultraviolet spectrophotometer. The total protein concentration of the transgenic and wild type plants was adjusted to 0.2. mu.g/. mu.L, and then 20. mu.L of each was dropped onto sterile filter paper of each fungal culture. In each fungusThe plate of (2) was supplemented with total proteins of different transgenic tobacco plants, and simultaneously with total proteins of wild type tobacco and a blank (protein extract) in parallel. The growth of the fungus was observed after several days of cultivation at 28 ℃ and evaluated based on the observationLrDIR1The results of the in vitro antifungal activity of the transgenic tobacco are shown in FIG. 3,LrDIR1the transgenic tobacco protein has obvious inhibition effect on the growth of fusarium oxysporum and phoma graminearum.
Sequence listing
<110> university of Kunming science
<120> Lilium regale Dirigent analogous protein gene LrDI 1 and application
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 867
<212> DNA
<213> Lilium regale Wilson
<400> 1
cgctagctgc aaaaaagttg accaagacag cttcatccta cctgccggtt catacaagag 60
aataatcgtt tgtatcctct atatatatct cacaacataa cgaacctctc tcatctcatc 120
tctcaagctt cccactactt gttccaatgg ccttcaattt ccccagcctc ctcctactct 180
tattagccgc caccacctcc tttgcagtac tagctacagc caagaagacc cagttgcagt 240
tctacgtaca cgtcataaac agcggcccca atgccaccac cgccgtagta gcaggcctca 300
acaagacatc ttccgcattc ggaaacatcg acgtgtacga caacatactg cgagtaggga 360
cagatccaag ctcagcaatc atcggaagga tccagggaat cgatgcccag gcttcactgg 420
gttcgccagc agtgacagcg gtgtacaatt ttgtgttcac aggtggtgcg tacaacggga 480
gcactcttgg catgatgggc taccatatca tgagccagcc gacatgggag cagagcgtga 540
ttgcagggac agggcagttc cgtctcgctc gaggatatgc aatagcgcag ctcgtcagct 600
acacccccgc ctacatagtc atcaacttca acgcttatgt tcttcattag atcttcatta 660
cagtataatg tttctgtttc tgttatgtat gttaaaacat caataaatct gtgtgccctt 720
tcatcaataa aactgttaca gaaaattcac tttgccgggc caaaactatg tacttaacac 780
caactttgat gacattactc gataaactca tttgagagaa tgtaaacaca gattgacaat 840
ataaaatcat gggttattca tcgtttc 867
<210> 2
<211> 167
<212> PRT
<213> Lilium regale Wilson
<400> 2
Met Ala Phe Asn Phe Pro Ser Leu Leu Leu Leu Leu Leu Ala Ala Thr
1 5 10 15
Thr Ser Phe Ala Val Leu Ala Thr Ala Lys Lys Thr Gln Leu Gln Phe
20 25 30
Tyr Val His Val Ile Asn Ser Gly Pro Asn Ala Thr Thr Ala Val Val
35 40 45
Ala Gly Leu Asn Lys Thr Ser Ser Ala Phe Gly Asn Ile Asp Val Tyr
50 55 60
Asp Asn Ile Leu Arg Val Gly Thr Asp Pro Ser Ser Ala Ile Ile Gly
65 70 75 80
Arg Ile Gln Gly Ile Asp Ala Gln Ala Ser Leu Gly Ser Pro Ala Val
85 90 95
Thr Ala Val Tyr Asn Phe Val Phe Thr Gly Gly Ala Tyr Asn Gly Ser
100 105 110
Thr Leu Gly Met Met Gly Tyr His Ile Met Ser Gln Pro Thr Trp Glu
115 120 125
Gln Ser Val Ile Ala Gly Thr Gly Gln Phe Arg Leu Ala Arg Gly Tyr
130 135 140
Ala Ile Ala Gln Leu Val Ser Tyr Thr Pro Ala Tyr Ile Val Ile Asn
145 150 155 160
Phe Asn Ala Tyr Val Leu His
165
<210> 3
<211> 21
<212> DNA
<213> Artificial sequence (Artificial)
<400> 3
cgctagctgc aaaaaagttg a 21
<210> 4
<211> 25
<212> DNA
<213> Artificial sequence (Artificial)
<400> 4
gaaacgatga ataacccatg atttt 25
Claims (2)
1. Lilium regale Dirigent analogous protein geneLrDIR1The nucleotide sequence is shown in SEQ ID NO. 1.
2. Lilium regale Dirigent analogous protein gene as claimed in claim 1LrDIR1In increasing the resistance of tobacco to fusarium oxysporum (F.), (Fusarium oxysporum) Phoma graminearum (A) and (B)Phoma herbarum) Use in resistance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110957491.9A CN113603757B (en) | 2021-08-20 | 2021-08-20 | Lily regale Dirigent similar protein gene LrDIR1 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110957491.9A CN113603757B (en) | 2021-08-20 | 2021-08-20 | Lily regale Dirigent similar protein gene LrDIR1 and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113603757A true CN113603757A (en) | 2021-11-05 |
CN113603757B CN113603757B (en) | 2023-05-26 |
Family
ID=78341403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110957491.9A Active CN113603757B (en) | 2021-08-20 | 2021-08-20 | Lily regale Dirigent similar protein gene LrDIR1 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113603757B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604477A (en) * | 2021-08-20 | 2021-11-05 | 昆明理工大学 | Lilium regale defensin antibacterial peptide gene LrDEF1 and application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020113A1 (en) * | 1996-11-08 | 1998-05-14 | Washington State University Research Foundation | Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
CN106244598A (en) * | 2016-09-21 | 2016-12-21 | 昆明理工大学 | Radix Notoginseng Dirigent albuminoid gene PnDIR1 and application |
CN110818783A (en) * | 2019-11-13 | 2020-02-21 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY2 and application thereof |
-
2021
- 2021-08-20 CN CN202110957491.9A patent/CN113603757B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020113A1 (en) * | 1996-11-08 | 1998-05-14 | Washington State University Research Foundation | Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
CN106244598A (en) * | 2016-09-21 | 2016-12-21 | 昆明理工大学 | Radix Notoginseng Dirigent albuminoid gene PnDIR1 and application |
CN110818783A (en) * | 2019-11-13 | 2020-02-21 | 昆明理工大学 | Lilium regale WRKY transcription factor gene LrWRKY2 and application thereof |
Non-Patent Citations (2)
Title |
---|
SENTHIL KUMAR THAMIL ARASAN等: "Characterization and expression analysis of dirigent family genes related to stresses in Brassica", 《PLANT PHYSIOLOGY AND BIOCHEMISTRY》 * |
SUBBURAJ,S.等: "dirigent-like protein [Lilium longiflorum],ACCESSION AUW34376", 《GENBANK》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604477A (en) * | 2021-08-20 | 2021-11-05 | 昆明理工大学 | Lilium regale defensin antibacterial peptide gene LrDEF1 and application |
CN113604477B (en) * | 2021-08-20 | 2023-03-24 | 昆明理工大学 | Lilium regale defensin antibacterial peptide gene LrDEF1 and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113603757B (en) | 2023-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110818783B (en) | Lilium regale WRKY transcription factor gene LrWRKY2 and application thereof | |
CN110818782B (en) | Lilium regale WRKY transcription factor gene LrWRKY3 and application thereof | |
CN105441460B (en) | A kind of Ming River lily WRKY transcription factor genes LrWRKY1 and application | |
CN109777810B (en) | Application of PUB41 gene as negative regulatory factor in improving resistance to tomato gray mold and bacterial wilt | |
CN110747202B (en) | Lilium regale WRKY transcription factor gene LrWRKY11 and application thereof | |
CN110734482B (en) | Lilium regale WRKY transcription factor gene LrWRKY4 and application thereof | |
Ojola et al. | Overexpression of rice thaumatin-like protein (Ostlp) gene in transgenic cassava results in enhanced tolerance to Colletotrichum gloeosporioides f. sp. manihotis | |
CN112831505B (en) | Pseudo-ginseng WRKY transcription factor gene PnWRKY15 and application thereof | |
CN108251432B (en) | Notoginseng disease course related protein genePnPRlikeAnd applications | |
CN107267526B (en) | Radix Notoginseng myb transcription factor gene PnMYB2 and its application | |
CN114317552A (en) | Gene PeERF1 for regulating and controlling salt tolerance of populus euphratica and application thereof | |
CN112359049B (en) | Lilium regale chitinase gene LrCHI2 and application thereof | |
CN117286150A (en) | Notoginseng disease course related protein 1 gene PnPR1-3 and its application | |
CN113603757A (en) | Lilium regale Dirigent similar protein gene LrDI 1 and application | |
CN103044534B (en) | Related gene of drought resistant medicago sativa as well as encoding protein and application of gene and protein | |
CN107267525B (en) | Application of panax notoginseng polygalacturonase inhibitor protein gene PnPGIP | |
CN108085318B (en) | Tomato long-chain non-coding RNA-lncRNA23468 and cloning method and application method thereof | |
CN107365794B (en) | Application of panax notoginseng chitinase gene PnCHI1 | |
CN116083445A (en) | CrBZR1 gene and application thereof | |
CN108707610B (en) | Notoginseng defensein antibacterial peptide genePnDEFL1And applications | |
CN109295068B (en) | Pseudo-ginseng sweet protein gene PnTLP2 and application | |
CN109576301B (en) | Application of ZmCOL3 gene and protein thereof in improving stem rot resistance of target plants | |
CN107326018B (en) | Method for cultivating plant low temperature resistant gene and transgenic low temperature resistant plant | |
CN113604477B (en) | Lilium regale defensin antibacterial peptide gene LrDEF1 and application thereof | |
Ren et al. | Genetic transformation and expression detection of tobacco by using a multi-gene plant transformation vector. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |